Post-approval studies (Phase 4)UnknownNCT00199147What this trial is testingEfficacy of G-CSF-Priming in Elderly AML PatientsWho this might be right forAcute Myeloid Leukemia Johann Wolfgang Goethe University Hospital 250
Testing effectiveness (Phase 2)Study completedNCT03961919What this trial is testingPhase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic TransplantWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesTransplant-Related Hematologic Malignancy Ciceri Fabio 15
Post-approval studies (Phase 4)Looking for participantsNCT06571825What this trial is testingRIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CRWho this might be right forAcute Myeloid Leukemia He Huang 118
Not applicableActive Not RecruitingNCT04822766What this trial is testingA Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 24
Not applicableStudy completedNCT04386928What this trial is testingALLO-SCT in Elderly Patients With Hematological DiseaseWho this might be right forHematologic DiseasesStem Cell Transplant Complications Gruppo Italiano Trapianto di Midollo Osseo 1,996
Not applicableStudy completedNCT07449364What this trial is testingAllogeneic Human Mesenchymal Stem Cell Infusion for Frailty PatientWho this might be right forFrailty in Older Adults Daewoong Group Indonesia 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199What this trial is testingVenetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCTWho this might be right forAcute Myeloid Leukemia Gruppo Italiano Trapianto di Midollo Osseo 100
Testing effectiveness (Phase 2)Study completedNCT01809847What this trial is testingOfatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic TransplantationWho this might be right forChronic Lymphatic Leukemia Technische Universität Dresden 20
Not applicableStudy completedNCT01095874What this trial is testingAllogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional StudyWho this might be right forMyelodysplasia Saint-Louis Hospital, Paris, France 164
Large-scale testing (Phase 3)Looking for participantsNCT07396480What this trial is testingFludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 TrialWho this might be right forVenentoclaxMyeloid MalignanciesConditioning+3 more First Affiliated Hospital of Zhejiang University 186
Testing effectiveness (Phase 2)Study completedNCT01404741What this trial is testing5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)Who this might be right forMyelodysplastic SyndromeChronic Myelomonocytic Leukemia Universitätsklinikum Hamburg-Eppendorf 191
Not applicableLooking for participantsNCT07420790What this trial is testingDesign and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III TrialWho this might be right forAcute Myeloid Leukemia Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941